glp 1 agonist abbreviation The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
doi:10.1001/jamainternmed.2023.6663 Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Shu Y., He X., Wu P., Liu Y., Ding Y., Zhang Q
These requirements mirror those that may have limited adoption of Rybelsus, the oral semaglutide from Novo Nordisk approved for diabetes in 2019
Talk to your healthcare provider about these differences to make choices that match your health needs and your comfort with risk
What side effects should I watch for, and when do they require medical attention
